Rapamycin is a classical mTOR inhibitor which has shown anti‐AD efficacy, which decreases fibrillary tangles and Aβ plaques in brain cells and restores cognitive impairment (Caccamo, Majumder, Richardson, Strong, & Oddo, 2010). Here, MTOR is linked to Alzheimer disease.